Fluid management in HPAPI manufacturing: Getting from high risk to controlled efficiency
In high potent active pharmaceutical ingredients (HPAPI) and antibody-drug conjugate (ADC) manufacturing, the most critical risks are often not visible at first glance. While much attention is given to payload potency and containment concepts, it is fluid handling that frequently determines whether a process is safe, reproducible, and scalable. HPAPI-containing liquids combine extreme biological activity with exceptionally high value per milliliter. As ADC designs evolve toward multi-linker and multi-payload formats, this value density continues to increase. Every fluid transfer step introduces risk: for the operator, for the environment, and for the product itself. In this context, fluid management is no longer a supporting operation. It becomes a core engineering discipline that directly impacts contamination control, Annex 1 alignment, and manufacturing efficiency. So how can manufacturers enhance safety levels and, at the same time, transform ADC handling into a far more time‑ and personnel‑efficient process? Read on to find out how efficiency gains of up to 90% in labour hours can be achieved. Fluid transfer equipment used in ADC and HPAPI manufacturing Liquid handling of HPAPIs typically relies on containment systems originally designed for aseptic processing. Common solutions include: Biosafety cabinets class II or class III: These biosafety cabinets are frequently used during early development or for small batch sizes, where predominantly manual operations are still performed. Restricted access barrier systems (RABS) and isolators: These systems provide a higher level of physical separation between operator and product and are widely adopted in commercial ADC fill-finish environments. Automated filling platforms integrated into closed single-use workflows. These fillers add an additional layer of process control by minimizing manual interventions and enabling recipe‑driven, fully documented operation. Aside from automated filling platforms, airflow behavior remains a critical consideration: Annex 1 places strong emphasis on predictable, unidirectional airflow and well‑controlled HEPA filter performance. Any fluid management solution operating in these environments must not disrupt laminar airflow through unnecessary movements, pressure fluctuations, or poorly engineered transfer interfaces. Challenges with isolators and RABS in ADC filling Isolators and RABS offer strong advantages in terms of operator protection and contamination control, but they introduce technical challenges that are often underestimated in HPAPI fluid management. One of the most common issues is pressure instability triggered by transfer interfaces such as alpha–beta ports. Each transfer event introduces short‑term pressure deviations that can disrupt unidirectional airflow within the critical zone. Air turbulence may also result from misaligned HEPA filters or from excessive mechanical movements of transfer systems. From an Annex 1 perspective, these disturbances are critical because they challenge the foundational assumptions of a consistently protected Grade A environment. If airflow visualization studies show instability, turbulence, or backflow, implementing corrective actions becomes complex and costly. Despite these challenges, isolators and RABS remain attractive solutions. They provide excellent operator safety against ADC cytotoxicity and support a high degree of automation, including the option to implement fully robotic fill-finish workflows for potent molecules. The key challenge is ensuring that fluid transfer technologies are engineered to complement the airflow concept rather than compromise it. Challenges with biosafety cabinets in HPAPI filling Biosafety cabinets are widely used in HPAPI development and clinical manufacturing. However, their limitations become evident as process requirements increase in complexity. Just like isolators, biosafety cabinets are sensitive to airflow disruptions caused by damaged or improperly installed HEPA filters. Manual interventions, frequent hand movements, and equipment changes further increase the risk of laminar flow disturbances. From a regulatory perspective, this creates a potential risk for Annex 1 alignment, especially when processes move toward commercial scale. In addition, operator protection relies heavily on procedural discipline rather than engineered physical separation, which is not ideal when handling highly potent ADC intermediates. Manual filling inside biosafety cabinets also introduces operational inefficiencies. Filling accuracy depends on operator skill, throughput is limited, and product loss due to handling errors becomes more likely. While biosafety cabinets can be a pragmatic solution for small volumes and early-stage batches, they offer limited scalability and often become a bottleneck during tech transfer. Single-use technologies for automated filling Single-use filling technologies address many of the limitations seen with open or semi-open systems. By creating a fully closed fluid path, these systems support Annex 1-aligned contamination control strategies while significantly reducing operator exposure to HPAPIs. In addition, filling ADCs into single-use bags or bottles with automated filling platforms can significantly reduce inefficiencies. An Irish manufacturer reported a reduction of more than 90% of labor hours per batch required when using automated filling platforms. [[download-1-email-detailed]] Automated platforms such as RoSS.FILL enable accurate and reproducible (recipe-driven) filling of liquid HPAPI intermediates with minimal manual interaction. Regardless of whether manufacturers use single-use bags or bottles as the bioprocess container, and independent of container size or type, the modular design of RoSS.FILL enables process flexibility. The closed design supports stable airflow conditions, as no open manipulations are required in the critical zone. Single-use assemblies simplify cleaning validation and allow rapid changeovers when scaling out production. Single Use Filling System - Single Use Support Takeaways for HPAPI manufacturers Fluid management has become a defining capability in HPAPI and ADC manufacturing. As molecules become more potent and fluid transfer processes more automated, the way liquids are filled and protected determines both regulatory robustness and economic success. Technologies that combine closed processing, automation, and single-use flexibility enable manufacturers to meet Annex 1 expectations while protecting operators and preserving every drop of valuable product. A well-designed fluid management strategy delivers measurable benefits throughout the ADC lifecycle. Operator safety improves through physical separation and aseptically closed and automated systems. Manufacturing processes become more reproducible, scalable, and suitable for scalable production. Automation and closed systems help ensure that high-value HPAPI liquids stay in the process where they belong. In a manufacturing environment where every drop counts, reducing avoidable losses has a direct impact on cost of goods and supply reliability. Learn how Single Use Support fluid management technologies support safe, scalable, and Annex 1-aligned HPAPI manufacturing. Learn how
READ MORE
